Internal Medicine · Nipomo, CA
NPI
1730317751
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
150 Tejas Pl
Nipomo, CA, 93444
Phone (805) 929-3211
Groups this clinician bills Medicare through
Medicare paid, 2024
$487
103 services
Medicare patients, 2024
53
Average age 67
Drug cost, 2024
$3.3M
5,957 prescriptions
Company payments, 2025
$41.21
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Teeranun Jirajariyavej was code 82947 (clinical chemistry), 48 times for 44 patients. In total Teeranun Jirajariyavej billed 103 services in 5 codes, and Medicare paid $487.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82947 Clinical Chemistry | Office | 48 | 44 | $3.85 | $185 |
| 83036 Blood Count | Office | 44 | 41 | $5.88 | $259 |
By year: 2022 $796 for 140 services; 2023 $927 for 189 services; 2024 $487 for 103 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 48 | 44 | $3.85 | $185 |
| 83036 Blood Count | 44 | 41 | $5.88 | $259 |
Medicare prescription drug claims, 2024
In 2024, the drug Teeranun Jirajariyavej prescribed most often to Medicare patients was Trulicity (Dulaglutide), with 524 prescriptions and refills. In total Teeranun Jirajariyavej wrote 5,957 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | 524 | 642 | 112 | $588K |
| Ozempic Semaglutide | 500 | 561 | 88 | $497K |
| Metformin Hcl Generic | 467 | 1,263 | 138 | $3,113 |
| Jardiance Empagliflozin | 343 | 894 | 100 | $470K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 287 | 598 | 78 | $29K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 287 | 531 | 77 | $91K |
| Humalog Kwikpen U-100 Insulin Lispro | 221 | 315 | 63 | $47K |
| Januvia Sitagliptin Phosphate | 216 | 577 | 74 | $283K |
| Levothyroxine Sodium Generic | 216 | 611 | 62 | $2,476 |
| Atorvastatin Calcium Generic | 212 | 624 | 78 | $1,684 |
| Rybelsus Semaglutide | 170 | 298 | 36 | $250K |
| Glipizide Er Glipizide | 162 | 461 | 44 | $2,997 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 159 | 313 | 62 | $16K |
| Farxiga Dapagliflozin Propanediol | 153 | 352 | 44 | $183K |
| Metformin Hcl Er Metformin Hcl | 136 | 382 | 42 | $1,239 |
Brand drugs: 3,827 claims; generic drugs: 1,691 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Teeranun Jirajariyavej $41.21 ($41.21 in general payments such as food, travel and fees) from 1 company. The largest payer was Tandem Diabetes Care, Inc. with $41.21.
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. TNDM | 2 | $41.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.